At Curate Biosciences we see a future where patients, clinicians, innovators, and payors routinely embrace cell and gene therapies against intractable disease. We foresee a world in which life-saving therapies are readily accessible to all, earlier in the treatment protocol, with longer persistence, fewer side effects, and with a positive impact to healthcare economics. To help make this future a reality, we focus on advancing our platform technology, Deterministic Cell Separation, to deliver greater quantities of the highest quality cellular starting materials, faster and less costly, to the innovators, developers, and clinicians pushing the boundaries of the possible.